ClinicalTrials.Veeva

Menu

FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Systemic Sclerosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Systemic sclerosis is a rare disease. The early cardiac disease affects 10% of patients sclérodemiques.

Heart transplantation in the early cardiac involvement in systemic sclerosis is exceptional.

we see patient data analysis with systemic sclerosis who used cardiac transplantation to understand the primitive cardiac damage associated with systemic sclerosis

Enrollment

9 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients meet the criteria for classification of systemic sclerosis
  • Adverse primitive heart that required a heart transplant
  • Patients who have given their verbal agreement to use their data for research purposes.

Exclusion criteria

  • Localized Scleroderma or sclerodermiform syndrome
  • Heart disease secondary to pulmonary or renal impairment
  • Refusal to participate in the study

Trial contacts and locations

0

Loading...

Central trial contact

Emmanuel CHATELUS, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems